Literature DB >> 26238503

Yiqi Huaju formula, a Chinese herbal medicine, reduces arterial pressure in salt‑sensitive hypertension by inhibiting renin‑angiotensin system activation.

Yan-Ming He1, Hong-Jie Yang1, Qiang Yang2, Jin-Gang Cui3, Tian-Zhan Wang2, Yi Chen2, Pei-Wei Wang1, Teng Zhang3, Wen-Jian Wang3.   

Abstract

Hypertension is a chronic disease with a high prevalence, and is associated with a high risk of vascular disease and premature death. Traditional Chinese medicine has been administered to treat hypertension for many years. In the present study, the effects of Yiqi Huaju formula (YQ; a compound used in traditional Chinese herbal medicine) were observed in salt‑sensitive hypertension, which was induced by a high‑salt and high‑fat (HSF) diet and the potential mechanism was investigated. YQ was prepared from five plant extracts and was dissolved in normal sodium chloride prior to use. Male Sprague‑Dawley rats were randomly divided into three groups, and fed either a normal diet (control), an HSF diet or an HSF diet with YQ. At week eight, blood pressure was measured and 24‑h urine samples were collected from all of the rats. The rats were subsequently sacrificed, and their blood was collected for biochemical analyses and kidney tissue samples were dissected for the immunohistochemical assay. YQ was observed to decrease the high arterial pressure and serum total cholesterol level, which had been induced by the HSF diet. It also enhanced the excretion of urinary angiotensinogen, Na+, and decreased the loss of urinary aldosterone, K+ and microalbuminuria. In addition, YQ inhibited the high mRNA expression level of renal renin, angiotensin II (Ang II), and Ang II receptor, type 1 (AT1R), and inhibited the protein expression of renal AT1R and Ang II receptor type 2, which had been induced by the HSF diet. These results indicate that YQ may reduce the arterial pressure in salt‑sensitive hypertension via the inhibition of renin‑angiotensin system activation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26238503     DOI: 10.3892/mmr.2015.4095

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  Effects of 12-Week Supplementation of a Polyherbal Formulation in Old Adults with Prehypertension/Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Tian Shen; Guoqiang Xing; Jingfen Zhu; Yong Cai; Shuxian Zhang; Gang Xu; Yi Feng; Donghua Li; Jianyu Rao; Rong Shi
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-14       Impact factor: 2.629

2.  Discovery of Novel Multi-target Inhibitor of angiotensin type 1 receptor and neprilysin inhibitors from Traditional Chinese Medicine.

Authors:  Xiaoqian Huo; Liansheng Qiao; Yankun Chen; Xi Chen; Yusu He; Yanling Zhang
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

3.  Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway.

Authors:  Yan-Ni Wang; Hong-Jiao Liu; Li-Li Ren; Ping Suo; Liang Zou; Ya-Mei Zhang; Xiao-Yong Yu; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

Review 4.  Traditional Chinese medicines in the management of cardiovascular diseases: a comprehensive systematic review.

Authors:  Kerry Layne; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2016-06-17       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.